Literature DB >> 15299088

hnRNP H binding at the 5' splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSHbeta genes.

Emanuele Buratti1, Marco Baralle, Laura De Conti, Diana Baralle, Maurizio Romano, Youhna M Ayala, Francisco E Baralle.   

Abstract

We have recently reported a disease-causing substitution (+5G > C) at the donor site of NF-1 exon 3 that produces its skipping. We have now studied in detail the splicing mechanism involved in analyzing RNA-protein complexes at several 5' splice sites. Characteristic protein patterns were observed by pulldown and band-shift/super-shift analysis. Here, we show that hnRNP H binds specifically to the wild-type GGGgu donor sequence of the NF-1 exon 3. Depletion analyses shows that this protein restricts the accessibility of U1 small nuclear ribonucleoprotein (U1snRNA) to the donor site. In this context, the +5G > C mutation abolishes both U1snRNP base pairing and the 5' splice site (5'ss) function. However, exon recognition in the mutant can be rescued by disrupting the binding of hnRNP H, demonstrating that this protein enhances the effects of the +5G > C substitution. Significantly, a similar situation was found for a second disease-causing +5G > A substitution in the 5'ss of TSHbeta exon 2, which harbors a GGgu donor sequence. Thus, the reason why similar nucleotide substitutions can be either neutral or very disruptive of splicing function can be explained by the presence of specific binding signatures depending on local contexts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15299088      PMCID: PMC514374          DOI: 10.1093/nar/gkh752

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  64 in total

Review 1.  Pre-mRNA splicing and human disease.

Authors:  Nuno André Faustino; Thomas A Cooper
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

2.  Correction of disease-associated exon skipping by synthetic exon-specific activators.

Authors:  Luca Cartegni; Adrian R Krainer
Journal:  Nat Struct Biol       Date:  2003-02

3.  A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer.

Authors:  H Min; C W Turck; J M Nikolic; D L Black
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

4.  A compensatory base change in U1 snRNA suppresses a 5' splice site mutation.

Authors:  Y Zhuang; A M Weiner
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

5.  A functional association between the 5' and 3' splice site is established in the earliest prespliceosome complex (E) in mammals.

Authors:  S Michaud; R Reed
Journal:  Genes Dev       Date:  1993-06       Impact factor: 11.361

Review 6.  The spliceosome: the most complex macromolecular machine in the cell?

Authors:  Timothy W Nilsen
Journal:  Bioessays       Date:  2003-12       Impact factor: 4.345

7.  A U1 snRNA:pre-mRNA base pairing interaction is required early in yeast spliceosome assembly but does not uniquely define the 5' cleavage site.

Authors:  B Séraphin; L Kretzner; M Rosbash
Journal:  EMBO J       Date:  1988-08       Impact factor: 11.598

8.  Can a 'patch' in a skipped exon make the pre-mRNA splicing machine run better?

Authors:  Emanuele Buratti; Francisco E Baralle; Franco Pagani
Journal:  Trends Mol Med       Date:  2003-06       Impact factor: 11.951

9.  Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9.

Authors:  Franco Pagani; Emanuele Buratti; Cristiana Stuani; Francisco E Baralle
Journal:  J Biol Chem       Date:  2003-05-05       Impact factor: 5.157

10.  Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1.

Authors:  I C Eperon; O V Makarova; A Mayeda; S H Munroe; J F Cáceres; D G Hayward; A R Krainer
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

View more
  38 in total

1.  Structural basis of G-tract recognition and encaging by hnRNP F quasi-RRMs.

Authors:  Cyril Dominguez; Jean-François Fisette; Benoit Chabot; Frédéric H-T Allain
Journal:  Nat Struct Mol Biol       Date:  2010-06-06       Impact factor: 15.369

2.  A G-rich element forms a G-quadruplex and regulates BACE1 mRNA alternative splicing.

Authors:  Jean-François Fisette; Daniel R Montagna; Mihaela-Rita Mihailescu; Michael S Wolfe
Journal:  J Neurochem       Date:  2012-03-13       Impact factor: 5.372

3.  Determinants of the inherent strength of human 5' splice sites.

Authors:  Xavier Roca; Ravi Sachidanandam; Adrian R Krainer
Journal:  RNA       Date:  2005-05       Impact factor: 4.942

Review 4.  Splicing in action: assessing disease causing sequence changes.

Authors:  D Baralle; M Baralle
Journal:  J Med Genet       Date:  2005-10       Impact factor: 6.318

5.  An apparent pseudo-exon acts both as an alternative exon that leads to nonsense-mediated decay and as a zero-length exon.

Authors:  Sushma-Nagaraja Grellscheid; Christopher W J Smith
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

6.  Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics.

Authors:  Xavier Roca; Andrew J Olson; Atmakuri R Rao; Espen Enerly; Vessela N Kristensen; Anne-Lise Børresen-Dale; Brage S Andresen; Adrian R Krainer; Ravi Sachidanandam
Journal:  Genome Res       Date:  2007-11-21       Impact factor: 9.043

7.  A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F.

Authors:  Joel L Coles; Martina Hallegger; Christopher W J Smith
Journal:  RNA       Date:  2008-11-26       Impact factor: 4.942

Review 8.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

9.  An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA.

Authors:  Marek Widera; Steffen Erkelenz; Frank Hillebrand; Aikaterini Krikoni; Darius Widera; Wolfgang Kaisers; René Deenen; Michael Gombert; Rafael Dellen; Tanya Pfeiffer; Barbara Kaltschmidt; Carsten Münk; Valerie Bosch; Karl Köhrer; Heiner Schaal
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor.

Authors:  Fatemeh Mohagheghi; Mercedes Prudencio; Cristiana Stuani; Casey Cook; Karen Jansen-West; Dennis W Dickson; Leonard Petrucelli; Emanuele Buratti
Journal:  Hum Mol Genet       Date:  2015-11-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.